GSK

Pfizer, GSK RSV shots get tepid recommendations from CDC advisory panel
Fierce Pharma
Thu, 06/22/23 - 10:19 am
RSV
GSK
Pfizer
vaccines
CDC
elderly
GSK says RSV vaccine for older adults provides protection over two seasons
CNBC
Wed, 06/21/23 - 11:57 am
GSK
RSV
vaccines
clinical trials
FDA delays approval decision on GSK's $1.9B blood cancer bet
Fierce Biotech
Fri, 06/16/23 - 09:52 am
GSK
FDA
momelotinib
blood cancer
Pfizer and GSK to battle for share of new RSV vaccine market
Biopharma Reporter
Wed, 06/14/23 - 11:33 am
Pfizer
GSK
FDA
vaccines
RSV
FDA sets the stage for adcomm on Sanofi, AZ's RSV prospect later this week
Fierce Pharma
Wed, 06/7/23 - 09:42 pm
Sanofi
AstraZeneca
GSK
Pfizer
RSV
vaccines
FDA
GSK’s RSV vaccine wins European approval
Stat
Wed, 06/7/23 - 09:59 am
GSK
RSV
Europe
vaccines
Arexvy
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Science finally figured out how to make effective RSV vaccines. Will seniors care?
Stat
Fri, 05/26/23 - 09:46 am
RSV
vaccines
elderly
Pfizer
GSK
Heightened US antitrust fears rattle biopharma
EP Vantage
Wed, 05/17/23 - 10:12 am
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
GSK to raise $1B by selling partial stake in former consumer health unit Haleon
Fierce Pharma
Fri, 05/12/23 - 11:44 am
GSK
Haleon
consumer health
GSK tees up Pfizer fight with pivotal meningitis vaccine data
Fierce Biotech
Fri, 05/12/23 - 10:23 am
GSK
Pfizer
vaccines
meningitis
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
drug launches
AbbVie
Almirall
Apellis Pharmaceuticals
Astellas
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eli Lilly
Genmab
GSK
Iveric Bio
Pfizer
Roche
SAGE Therapeutics
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Vertex Pharmaceuticals
Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks
BioSpace
Wed, 05/10/23 - 10:18 am
Gilead Sciences
GSK
momelotinib
Roche
Eli Lilly
lebrikizumab
Merck
Zejula
Amgen
Galenica
Veltassa
Cubicin
Iteos – and GSK – keep the faith
EP Vantage
Tue, 05/9/23 - 10:40 am
GSK
iTeos Therapeutics
anti-TIGIT
Roche
belrestotug
Cut Short by RSV: GSK’s compelling ad ties into recent FDA approval
Medical Marketing and Media
Mon, 05/8/23 - 11:32 pm
GSK
RSV
vaccines
DTC ads
FDA
GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine
Clinical Trials Arena
Mon, 05/8/23 - 11:27 pm
GSK
CureVac
vaccines
MRNA
Flu
FDA approves first RSV vaccine, clearing GSK’s Arexvy for older adults
BioPharma Dive
Wed, 05/3/23 - 10:49 pm
GSK
RSV
vaccines
Arexvy
FDA
The race for gold: Closing in on the first RSV vaccine
Pharmaphorum
Wed, 05/3/23 - 11:37 am
vaccines
RSV
GSK
Pfizer
Moderna Therapeutics
'More in the hopper': European Big Pharmas hint M&A could ramp up
Fierce Biotech
Mon, 05/1/23 - 10:15 am
Europe
M&A
GSK
Novartis
Roche
GSK's RSV vaccine first to get EU regulator's nod
Reuters
Fri, 04/28/23 - 10:12 am
GSK
vaccines
RSV
Europe

Pages